COMMUNIQUÉS West-GlobeNewswire

Communiqué de presse : Sanofi en discussions pour céder une participation majoritaire dans Opella
11/10/2024
Sanofi en discussions pour céder une participation majoritaire dans Opella Paris, 11 octobre 2024 . Sanofi a annoncé aujourd'hui avoir entamé des négociations avec CD&R pour la cession potentielle d’une [...]
NMD Pharma to Present Data on its Skeletal Muscle Targeted Therapy for Rare Neuromuscular Diseases at the 2024 AANEM Annual Meeting
11/10/2024
NMD Pharma to Present Data on its Skeletal Muscle Targeted Therapy for Rare Neuromuscular Diseases at the 2024 AANEM Annual Meeting Aarhus, Denmark, 11 October 2024 – NMD Pharma A/S, a clinical-stage biotech company [...]
Sandoz US launches generic paclitaxel in single-dose vial, further expanding US oncology portfolio
11/10/2024
MEDIA RELEASE First FDA-approved abbreviated new drug application (ANDA) to reference medicine Single-dose 100 mg vial for intravenous use, approved for metastatic breast cancer Launch expected to be near-term growth [...]
Crinetics Pharmaceuticals Announces October 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10/10/2024
SAN DIEGO, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on October 10, 2024, the Compensation Committee of Crinetics’ Board of Directors granted non-qualified [...]
Procedure of the Annual General Meeting
10/10/2024
ANNOUNCEMENT NO. 277 10 October 2024 Procedure of the Annual General Meeting The Annual General Meeting of ChemoMetec A/S was held on 10 October 2024 at 5.30 p.m. at Nordsjællands KonferenceCenter. At the Annual General [...]
Codexis to Report Third Quarter 2024 Financial Results on October 31
10/10/2024
REDWOOD CITY, Calif., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced that it will report [...]
PacBio to Report Third Quarter 2024 Financial Results on November 7, 2024
10/10/2024
MENLO PARK, Calif., Oct. 10, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its third quarter 2024 financial results on Thursday, November 7, [...]
QIAGEN expands automated liquid biopsy portfolio to enhance oncology, prenatal care and organ transplant applications
10/10/2024
Portfolio expansion reinforces QIAGEN’s leadership in automated solutions for non-invasive liquid biopsy applications combined with complete workflows // New ccfDNA Kit upgrade with urine protocol for use on EZ1 and 2 [...]
SELLAS Life Sciences to Participate in Fireside Chat at the 2024 Maxim Healthcare Virtual Summit
10/10/2024
NEW YORK, Oct. 10, 2024 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a [...]
Mercy Places First Commercial Eversense 365: The World’s First and Only 365-Day Continuous Glucose Monitor
10/10/2024
Senseonics’ Eversense 365 is approved in the US as an integrated continuous glucose monitoring (iCGM) system for people with Type 1 and Type 2 diabetes aged 18 and older Commercial launch by Ascensia Diabetes Care [...]
Sutro Biopharma Highlights Next-Generation ADC Innovation and Near-term Pipeline at Research Forum
10/10/2024
Proprietary cell-free platform enables the design of next-generation ADCs intended to broaden addressable patient populations STRO-004 (tissue factor ADC) preclinical data has demonstrated greater anti-tumor activity [...]
Allakos Announces Phase 1 Trial Results of Subcutaneous AK006 in Healthy Volunteers
10/10/2024
– Subcutaneously administered AK006 showed approximately 77% bioavailability and prolonged receptor occupancy on mast cells – – Subcutaneous AK006 was well-tolerated with a favorable safety profile – – Top-line Phase 1 [...]
Appili Therapeutics – Press Release Correction
10/10/2024
HALIFAX, Nova Scotia, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX:APLI; OTCPink: APLIF) (the “Company” or “Appili”), announces correction to its press release entitled “Appili Therapeutics Announces [...]
EUROAPI completes the financing of its FOCUS-27 plan and moves forward with its execution
10/10/2024
Press Release €451M Revolving Credit Facility refinanced with a maturity extended to February 2029 Issuance of a €200M Perpetual Deeply Subordinated Hybrid Bond subscribed by Sanofi €54M product capacity reservation for [...]
EUROAPI finalise le financement de son plan FOCUS-27 et poursuit son exécution
10/10/2024
Communiqué de presse Contrat de crédit RCF de €451M refinancé avec une maturité étendue à février 2029 Obligation Hybride Super Subordonnée de €200M souscrite par Sanofi Accord de €54M conclu avec Sanofi pour la [...]
QC Kinetix Celebrates PA Week Honoring Physician Assistants as 'The Miraculous Midlevel'
10/10/2024
QC Kinetix, a fast-growing regenerative medicine franchise that offers a cutting-edge, non-surgical alternative to joint and pain relief, recognizes PA Week Charlotte, North Carolina, Oct. 10, 2024 (GLOBE NEWSWIRE) -- [...]
Olansky Dermatology & Aesthetics co-founder Dr. David Olansky retires after more than 40 years of clinical practice
10/10/2024
ATLANTA, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Olansky Dermatology & Aesthetics –Georgia’s top-rated dermatology practice– is announcing the retirement of Dr. David Olanksy, a trusted expert in the field of dermatology [...]
Monthly information related to total number of voting rights and shares composing the share capital – October 8, 2024
10/10/2024
Listing market: Euronext Paris (Market segment C - ISIN Code: FR001400K4B1- Symbol: PHXM) Website : www.phaxiam.com Date Total of shares composing the share capital Total of brut (1) voting rights Total of net ( 2) [...]
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 8 octobre 2024
10/10/2024
Place de cotation : Euronext Paris (Compartiment C - Code ISIN : FR001400K4B1 – Symbole : PHXM) Site web : www.phaxiam.com Date Nombre total d’actions composant le capital social Nombre total de droits de vote brut (1) [...]

Pages